Hanmi launches Eppe in Korea, undercutting Mounjaro's launch price by more than half
South Korean doctors can prescribe Hanmi Pharmaceutical's Eppe, the country's first home-grown GLP-1 obesity injection, from 29 October. It's priced at less than half of Mounjaro's initial price in Korea, turning the market into a three-way race with Wegovy and Mounjaro. It's an early sign that cheaper regional rivals are arriving.
Source: KED Global (28 Oct 2026). Image: KED Global.